The present invention provides conjugates formed by coupling argininedeiminase and polyethylene glycol having arginine deiminase activity for useinpreventing or treating a cancer. The invention also provides a method ofprolonging the in vivo half-life and anti-cancer efficacy of the argininedeiminase in the conjugate.